The Cheshire and Merseyside Cardiac Board is proud to share the development of an integrated end-to-end pathway which will improve access and outcomes for people with heart failure.

The pathway has been developed with patients, GPs, cardiologists, heart failure specialist nurses, pharmacists, cardiac rehab teams and other specialists (palliative care, kidney specialists) across Cheshire and Merseyside, integrating primary, secondary and tertiary care.

The event is funded by Novartis and AstraZeneca* in partnership with Cheshire and Merseyside Health and Care Partnership and heart failure charity, Pumping Marvellous.

The event will be chaired by Dr Joe Mills, Consultant Cardiologist at Liverpool Heart and Chest Hospital / Clinical Network Lead Cheshire and Merseyside Cardiac Board, and Jonathan Develing, Director of Strategic Partnerships, Liverpool Heart and Chest Hospital.

Sessions include:

Patient stories
The role of heart failure multidisciplinary teams in relation to Cheshire and Merseyside pathway
The role of primary care in relation to Cheshire and Merseyside pathway
The role of other specialists in heart failure in relation to Cheshire and Merseyside pathway

Please see the attached agenda for full details and expert speakers from across the region.

Six Royal College of Practitioners CPD points have been applied for for this event.

Attendance at Haydock Park is limited to 100 delegates. Live streaming and recording options will also be available - details to follow.

*Novartis and AstraZeneca have no input into the conference content.

Cheshire and Merseyside Heart Failure Pathway Launch